Article info
PDFOsteoarthritis
Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial
- Correspondence to Professor Pascal Richette, service de rhumatologie, Hôpital Lariboisière, Paris, Île-de-France, France; pascal.richette{at}aphp.fr
Citation
Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial
Publication history
- Received July 7, 2020
- Revised September 15, 2020
- Accepted September 24, 2020
- First published October 14, 2020.
Online issue publication
February 11, 2021
Article Versions
- Previous version (14 October 2020).
- Previous version (20 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.